Our observations indicate that over-activation of NK cells might facilitate HBV-associated HCC development, suggesting that the host genetic background of KIR and HLA loci should probably be taken into consideration when IFN therapy is applied in hepatitis B patients. Here, KIR3DL1 is linked to hepatocellular carcinoma.